These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 759567)

  • 21. Determination of methyldopa and metabolites in human serum by high-performance liquid chromatography with electrochemical detection.
    Cooper MJ; O'Dea RF; Mirkin BL
    J Chromatogr; 1979 Apr; 162(4):601-4. PubMed ID: 528671
    [No Abstract]   [Full Text] [Related]  

  • 22. Determination of 3,4-dihydroxyphenylalanine (DOPA) in plasma and cerebrospinal fluid by high performance liquid chromatography with electrochemical detection.
    Boomsma F; van der Hoorn FA; Man in 't Veld AJ; Schalekamp MA
    Clin Chim Acta; 1988 Nov; 178(1):59-69. PubMed ID: 3147824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
    Bianchine JR; Messiha FS; Hsu TH
    Clin Pharmacol Ther; 1972; 13(4):584-94. PubMed ID: 5042372
    [No Abstract]   [Full Text] [Related]  

  • 24. Determination of free methyldopa in plasma by high-pressure liquid chromatography and electrochemical detection.
    Kochak GM; Mason WD
    J Pharm Sci; 1980 Aug; 69(8):897-900. PubMed ID: 7400933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of parkinsonian syndromes and plasmatic DOPA levels. Effects of L-DOPA and 3-OMD, administered alone or combined, with or without a decarboxylase inhibitor].
    Geissbühler F; Gaillard JM; Eisenring JJ; Krassoievitch M; Yanniotis G; Tissot R
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):38-44. PubMed ID: 5041348
    [No Abstract]   [Full Text] [Related]  

  • 26. The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
    Lloyd KG; Davidson L; Hornykiewicz O
    J Pharmacol Exp Ther; 1975 Dec; 195(3):453-64. PubMed ID: 489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on rheomelanins. I. The formation of rheomelanins in human blood plasma from catecholamines, from L-dopa and from some of their derivatives.
    Hegedus ZL; Altschule MD
    Arch Int Physiol Biochim; 1970 Aug; 78(3):443-59. PubMed ID: 4097994
    [No Abstract]   [Full Text] [Related]  

  • 28. The metabolic pathways of L-3-O-methyldopa.
    Bartholini G; Kuruma I; Pletscher A
    J Pharmacol Exp Ther; 1972 Oct; 183(1):65-72. PubMed ID: 5080035
    [No Abstract]   [Full Text] [Related]  

  • 29. [Abnormal movements caused by L-DOPA in patients with Parkinson's disease: correlation with the plasma concentrations of DOPA and O-methyl-DOPA].
    Lhermitte F; Agid Y; Feuerstein C; Serre F; Signoret JL; Studler JM; Bonnet AM
    Rev Neurol (Paris); 1977; 133(8-9):445-54. PubMed ID: 929037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Method for the determination of gamma-L-glutamyl-L-dihydroxyphenylalanine and its major metabolites L-dihydroxyphenylalanine, dopamine and 3,4-dihydroxyphenylacetic acid by high-performance liquid chromatography with electrochemical detection.
    Cummings J; Matheson LM; Smyth JF
    J Chromatogr; 1990 Jun; 528(1):43-53. PubMed ID: 2117019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assay and stability of alpha-methyldopa in man using high-performance liquid chromatography with electrochemical detection.
    Ong H; Sved S; Beaudoin N
    J Chromatogr; 1982 May; 229(2):433-8. PubMed ID: 7096478
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolism of 3,4-dihydroxyphenylalanine by isolated perfused rat liver.
    Tyce GM
    Biochem Pharmacol; 1971 Dec; 20(12):3447-62. PubMed ID: 5132891
    [No Abstract]   [Full Text] [Related]  

  • 33. Determination of dopa, dopamine, dopac, epinephrine, norepinephrine, alpha-monofluoromethyldopa and alpha-difluoromethyldopa in various tissues of mice and rats using reversed-phase ion-pair liquid chromatography with electrochemical detection.
    Wagner J; Palfreyman M; Zraika M
    J Chromatogr; 1979 Sep; 164(1):41-54. PubMed ID: 541397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).
    Yahr MD; Duvoisin RC; Mendoza MR; Schear MJ; Barrett RE
    Trans Am Neurol Assoc; 1971; 96():55-8. PubMed ID: 5159129
    [No Abstract]   [Full Text] [Related]  

  • 35. Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa.
    Rodgers KJ; Hume PM; Morris JG; Dean RT
    J Neurochem; 2006 Aug; 98(4):1061-7. PubMed ID: 16771833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of DOPA, dopamine, and 5-S-cysteinyl-DOPA in plasma, urine, and tissue samples by high-performance liquid chromatography with electrochemical detection.
    Ito S; Kato T; Maruta K; Fujita K; Kurahashi T
    J Chromatogr; 1984 Nov; 311(1):154-9. PubMed ID: 6440898
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats.
    Kvetnanský R; Goldstein DS; Weise VK; Holmes C; Szemeredi K; Bagdy G; Kopin IJ
    J Neurochem; 1992 Jun; 58(6):2296-302. PubMed ID: 1573408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-DOPA treatment in Parkinson's disease: effect on dopamine and related substances in discrete brain regions.
    Davidson L; Lloyd K; Dankova J; Hornykiewicz O
    Experientia; 1971 Sep; 27(9):1048-9. PubMed ID: 5116129
    [No Abstract]   [Full Text] [Related]  

  • 39. Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography.
    Nagatsu T; Oka K; Kato T
    J Chromatogr; 1979 Jul; 163(3):247-52. PubMed ID: 44298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of methyldopa in plasma using high-performance liquid chromatography with electrochemical detection. Application to pharmacokinetic/bioavailability studies.
    Dilger C; Salama Z; Jaeger H
    Arzneimittelforschung; 1987 Dec; 37(12):1399-401. PubMed ID: 3449071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.